Statim

Free

★ 5 • Updated Aug 17, 2026, 02:00 AM

Statim is a free, web-based pharmaceutical intelligence platform that consolidates drug information, intelligent safety analysis, and clinical evidence into a unified workspace.

Use Cases ▼

Find concise, cited drug summaries for clinical decision support

Analyze FDA FAERS adverse event data for demographic risks and safety signals

Search for drug information using natural clinical language

Ask complex medication questions and get literature-grounded answers

Track new FDA drug approvals and regulatory tags

Evaluate off-label adverse effects and interaction severity

What Problem It Solves ▼

Statim addresses the fragmented pharmaceutical information landscape by unifying drug reference, safety analysis, and clinical evidence into a single free workspace. It eliminates the need to consult dozens of separate databases and provides AI-powered, literature-grounded answers with citations, helping healthcare professionals make faster, evidence-based medication decisions.

Key Features ▼

✓

100% free with no subscriptions

✓

Zero patient data collection

✓

AI grounded in peer-reviewed literature (PubMed, Cochrane)

✓

Unified workspace reduces fragmented research

✓

Advanced FAERS safety intelligence with demographic and off-label insights

Overview

Statim is a free, web-based pharmaceutical intelligence platform that consolidates drug information, intelligent safety analysis, and clinical evidence into a unified workspace. It reduces the need to navigate multiple fragmented databases by providing smart search, clinical Q&A, FDA approval tracking, and a drug directory. The AI is grounded in peer-reviewed literature from PubMed and the Cochrane Library.

Full Description ▼

Statim's Clinical Safety Intelligence (CSI) engine analyzes FDA Adverse Event Reporting System (FAERS) data to generate structured insights including demographic risks, off-label effects, context and adherence factors, severity distribution, and interaction severity. The platform also offers real-time tracking of novel drug approvals and regulatory tags such as Breakthrough Therapy and Priority Review.

The service is 100% free with zero subscriptions and collects zero patient data, aiming to support clinical pharmacists, specialists, and medical directors by cutting research time in half and providing cited, actionable intelligence.